Jaguar Health Inc (JAGX)

[Tahoe2468]

Nice article today


Trading currently at 27 cents and with a market cap of $74 million, Jaguar Health (NASDAQ:JAGX) sits firmly inside the penny stock category. The company’s name gives a clue as to its mission, which is to use chemical derivatives from natural sources found in rainforests to develop novel pharmaceuticals.

These proprietary prescription medications are directed towards both people and animals with gastrointestinal issues such as an overactive bowel. Currently, one of the company’s subsidiaries, Napo Pharmaceuticals, is working to develop and commercialize a drug named crofelemer. This drug aims to treat chemotherapy-induced overactive bowel, which is a common symptom for many cancer patients.

With the drug currently in Phase 3 clinical trials, the potential for a spike in JAGX’s value is real. Though it will likely be a few more years, should the drug achieve regulatory approval, it could become a staple among chemotherapy treatments for symptom prevention. Pair this with aging populations around the developed world, and the demand for crofelemer could drive JAGX up even further

https://investorplace.com/2024/05/want-10000-invest-1000-in-these-3-penny-stocks-now/